Medscape: PEPFAR spared, but concerns about global HIV response remain
“In Ukraine, we count on the US decision that PEPFAR will continue to fund PrEP,” Andriy Klepikov, PhD, executive director of the Alliance for Public Health, told Medscape Medical News. “We hope that PEPFAR will continue PrEP for key populations (not only for pregnant and breastfeeding women), but there is no confirmation yet,” he added.
MedPage Today: Devastating effects from PEPFAR, USAID cuts are hitting Africa, experts say
/free registration required/
“The impacts are already clear and devastating: declines in testing, diagnoses, treatment initiation, and viral suppression, especially among vulnerable groups like children and key populations,” Eric Cioè-Peña, MD, MPH, of the Center for Global Health at Northwell Health and Zucker School of Medicine at Hofstra/Northwell in Hempstead, New York, told MedPage Today. “These aren’t just numbers; they’re people losing access to the most effective public health intervention of our time,” he added.
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.